E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/30/2018 in the Prospect News Structured Products Daily.

New Issue: Morgan Stanley sells $1.2 million inverse dual directional trigger PLUS on ETFs

By Wendy Van Sickle

Columbus, Ohio, Aug. 30 – Morgan Stanley Finance LLC priced $1.2 million of 0% inverse dual directional trigger Performance Leveraged Upside Securities due Oct. 30, 2020 linked to the separate performance of the Invesco QQQ Trust, series 1, the SPDR S&P Biotech ETF and the VanEck Vectors Semiconductor ETF, according to a 424B2 with the Securities and Exchange Commission.

The notes are guaranteed by Morgan Stanley.

If the final share price of each ETF is less than its initial share price, the payout at maturity will be par plus 1.5 times the decrease of the best performing ETF.

If the final share price of any ETF is greater than its initial share price but less than the trigger level, 134% of the initial level, the payout at maturity will be par plus the increase of the best performing ETF.

Otherwise, investors will lose 1% for each 1% gain of the best performing ETF, subject to a minimum payout of $0.

Morgan Stanley & Co. LLC is the agent.

Issuer:Morgan Stanley Finance LLC
Guarantor:Morgan Stanley
Issue:Dual directional trigger Performance Leveraged Upside Securities
Underlying ETFs:Invesco QQQ Trust, series 1, SPDR S&P Biotech ETF and VanEck Vectors Semiconductor ETF
Amount:$1,198,000
Maturity:Oct. 30, 2020
Coupon:0%
Price:Par
Payout at maturity:If final share price of each ETF is less than initial share price, par plus 1.5 times the decrease of the best performing ETF; if final share price of any ETF is greater than initial share price but less than trigger level par plus the increase of the best performing ETF; otherwise, 1% loss for each 1% gain of best performing ETF, subject to a minimum payout of $0
Initial levels:$184.34 for QQQ, $98.00 for Biotech and $108.61 for Semiconductor
Trigger level:$247.016 for QQQ, $131.32 for Biotech and $145.537 for Semiconductor; 134% of initial levels
Pricing date:Aug. 27
Settlement date:Aug. 30
Agent:Morgan Stanley & Co. LLC
Fees:1%
Cusip:61768DCH6

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.